{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T17:37:04Z","timestamp":1768325824419,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Handok Jeseok Foundation"},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00245453"],"award-info":[{"award-number":["RS-2023-00245453"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00210-023-02889-5","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T08:01:30Z","timestamp":1702713690000},"page":"4403-4418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Population pharmacokinetic modeling of levodropropizine: extended application to comparative analysis between commercial formulations and exploration of pharmacokinetic effects of diet"],"prefix":"10.1007","volume":"397","author":[{"given":"Seung-Hyun","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Hun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Bok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"2889_CR1","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.healun.2007.11.029","volume":"27","author":"N Al-Naamani","year":"2008","unstructured":"Al-Naamani N, Maarouf O, Wilt J, D\u2019Ovidio F, Sonett J, Arcasoy S, Nickolas T, Lederer D, Kawut S (2008) 25: the modification of diet in renal disease (MDRD) formula predicts kidney failure after lung transplantation. J Heart Lung Transplant 27:S69","journal-title":"J Heart Lung Transplant"},{"key":"2889_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.3390\/children2020244","volume":"2","author":"HK Batchelor","year":"2015","unstructured":"Batchelor HK (2015) Influence of food on paediatric gastrointestinal drug absorption following oral administration: a review. Children 2:244\u2013271","journal-title":"Children"},{"key":"2889_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pupt.2019.03.003","volume":"56","author":"S Birring","year":"2019","unstructured":"Birring S, de Blasio F, Dicpinigaitis PV, Fontana G, Lanata L, Page C, Saibene F, Zanasi A (2019) Antitussive therapy: a role for levodropropizine. Pulm Pharmacol Ther 56:79\u201385","journal-title":"Pulm Pharmacol Ther"},{"key":"2889_CR4","first-page":"178","volume":"3","author":"M Borsa","year":"1991","unstructured":"Borsa M, Glavenna G, Ferrari M, Canali S, Giachetti C, Zanolo G (1991) Linearity of levodropropizine, a new antitussive drug, in the healthy volunteer. Eur J Drug Metab Pharmacokinet 3:178\u2013184","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2889_CR5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3109\/10837450.2013.778871","volume":"19","author":"Q-R Cao","year":"2014","unstructured":"Cao Q-R, Piao Y-N, Choi J-S, Liu Y, Yang M, Cui J-H (2014) Design, in vitro release characterization and pharmacokinetics of novel controlled release pellets containing levodropropizine. Pharm Dev Technol 19:296\u2013303","journal-title":"Pharm Dev Technol"},{"key":"2889_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.pupt.2012.05.010","volume":"25","author":"F De Blasio","year":"2012","unstructured":"De Blasio F, Dicpinigaitis PV, De Danieli G, Lanata L, Zanasi A (2012) Efficacy of levodropropizine in pediatric cough. Pulm Pharmacol Ther 25:337\u2013342","journal-title":"Pulm Pharmacol Ther"},{"key":"2889_CR7","unstructured":"Drugbank (2023) Levodropropizine. https:\/\/go.drugbank.com\/drugs\/DB12472. Accessed 30 August 2023"},{"key":"2889_CR8","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1651-2227.2011.02580.x","volume":"101","author":"R El Edelbi","year":"2012","unstructured":"El Edelbi R, Lindemalm S, Eksborg S (2012) Estimation of body surface area in various childhood ages\u2013validation of the Mosteller formula. Acta Paediatr 101:540\u2013544","journal-title":"Acta Paediatr"},{"key":"2889_CR9","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1592\/phco.29.6.649","volume":"29","author":"ED Hermsen","year":"2009","unstructured":"Hermsen ED, Maiefski MM, Florescu MC, Qiu F, Rupp ME (2009) Comparison of the modification of diet in renal disease and Cockcroft-Gault equations for dosing antimicrobials. Pharmacotherapy 29:649\u2013655","journal-title":"Pharmacotherapy"},{"key":"2889_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1442-200x.2005.02045.x","volume":"47","author":"M Hotta","year":"2005","unstructured":"Hotta M, Li Y, Anme T, Ushijima H (2005) Risk factors for low Kaup index among children in rural ethnic minority areas of Yunnan, China. Pediatr Int 47:147\u2013153","journal-title":"Pediatr Int"},{"key":"2889_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5414\/CP201730","volume":"51","author":"J-W Jang","year":"2013","unstructured":"Jang J-W, Seo J-H, Jo M-H, Lee Y-J, Cho Y-W, Yim S-V, Lee K-T (2013) Relative bioavailability of levodropropizine 60 mg capsule and syrup formulations in healthy male Korean volunteers: a singledose, randomized-sequence, open-label, two-way crossover study. Int J Clin Pharmacol Ther 51:152\u2013160","journal-title":"Int J Clin Pharmacol Ther"},{"key":"2889_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/ph16020161","volume":"16","author":"J-H Jang","year":"2023","unstructured":"Jang J-H, Jeong S-H, Lee Y-B (2023a) Population pharmacokinetic modeling of zaltoprofen in healthy adults: exploring the dosage regimen. Pharmaceuticals 16:161","journal-title":"Pharmaceuticals"},{"key":"2889_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/phar.2762","volume":"43","author":"JH Jang","year":"2023","unstructured":"Jang JH, Jeong SH, Lee YB (2023b) Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic-pharmacodynamic model. Pharmacotherapy 43:145\u2013157","journal-title":"Pharmacotherapy"},{"key":"2889_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.12793\/jkscpt.2013.21.2.113","volume":"21","author":"S Jeon","year":"2013","unstructured":"Jeon S, Lee J, Hong T, Paek J, Han S, Yim D-S (2013) Pharmacokinetics and safety of levodropropizine controlled release tablet after repeated dosing in healthy male volunteers. J Korean Soc Clin Pharmacol Ther 21:113\u2013119","journal-title":"J Korean Soc Clin Pharmacol Ther"},{"key":"2889_CR15","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/pharmaceutics13050754","volume":"13","author":"S-H Jeong","year":"2021","unstructured":"Jeong S-H, Jang J-H, Cho H-Y, Lee Y-B (2021) Population pharmacokinetic analysis of cefaclor in healthy Korean subjects. Pharmaceutics 13:754","journal-title":"Pharmaceutics"},{"key":"2889_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/pharmaceutics14040771","volume":"14","author":"S-H Jeong","year":"2022","unstructured":"Jeong S-H, Jang J-H, Cho H-Y, Lee Y-B (2022a) Population pharmacokinetic (Pop-PK) analysis of torsemide in healthy Korean males considering CYP2C9 and OATP1B1 genetic polymorphisms. Pharmaceutics 14:771","journal-title":"Pharmaceutics"},{"key":"2889_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40005-021-00550-y","volume":"52","author":"S-H Jeong","year":"2022","unstructured":"Jeong S-H, Jang J-H, Lee Y-B (2022b) Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism. J Pharm Investig 52:109\u2013127","journal-title":"J Pharm Investig"},{"key":"2889_CR18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2147\/DDDT.S146958","volume":"12","author":"S Lee","year":"2018","unstructured":"Lee S, Nam K-Y, Oh J, Lee S, Cho S-M, Choi Y-W, Cho J-Y, Lee B-J, Hong JH (2018) Evaluation of the effects of food on levodropropizine controlled-release tablet and its pharmacokinetic profile in comparison to that of immediate-release tablet. Drug Des Devel Ther 12:1413\u20131420","journal-title":"Drug Des Devel Ther"},{"key":"2889_CR19","doi-asserted-by":"crossref","first-page":"155","DOI":"10.15586\/aei.v49i4.206","volume":"49","author":"GL Marseglia","year":"2021","unstructured":"Marseglia GL, Manti S, Chiappini E, Brambilla I, Caffarelli C, Calvani M, Cardinale F, Cravidi C, Duse M, Martelli A (2021) Acute cough in children and adolescents: a systematic review and a practical algorithm by the Italian Society of Pediatric Allergy and Immunology. Allergol Immunopathol 49:155\u2013169","journal-title":"Allergol Immunopathol"},{"key":"2889_CR20","unstructured":"Medindia (2020) Levodropropizine - Indications, Dosage, Side Effects and Precautions. https:\/\/www.medindia.net\/doctors\/drug_information\/levodropropizine.htm. Accessed 6 August 2023"},{"key":"2889_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1517\/17425255.2.5.715","volume":"2","author":"S Neervannan","year":"2006","unstructured":"Neervannan S (2006) Preclinical formulations for discovery and toxicology: physicochemical challenges. Expert Opin Drug Metab Toxicol 2:715\u2013731","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2889_CR22","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1097\/MEG.0000000000001353","volume":"31","author":"J Rahmani","year":"2019","unstructured":"Rahmani J, Miri A, Namjoo I, Zamaninour N, Maljaei MB, Zhou K, Cerneviciute R, Mousavi SM, Varkaneh HK, Salehisahlabadi A (2019) Elevated liver enzymes and cardiovascular mortality: a systematic review and dose\u2013response meta-analysis of more than one million participants. Eur J Gastroenterol Hepatol 31:555\u2013562","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2889_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1476-5381.1996.tb15271.x","volume":"117","author":"H Shams","year":"1996","unstructured":"Shams H, Daffonchio L, Scheid P (1996) Effects of levodropropizine on vagal afferent C-fibres in the cat. Br J Pharmacol 117:853\u2013858","journal-title":"Br J Pharmacol"},{"key":"2889_CR24","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function\u2014measured and estimated glomerular filtration rate. N Engl J Med 354:2473\u20132483","journal-title":"N Engl J Med"},{"key":"2889_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jchromb.2005.01.029","volume":"819","author":"Y Tang","year":"2005","unstructured":"Tang Y, Zhao L, Wang Y, Fawcett JP, Gu J (2005) Rapid and sensitive liquid chromatography\u2013tandem mass spectrometry method for the quantitation of levodropropizine in human plasma. J Chromatogr B 819:185\u2013189","journal-title":"J Chromatogr B"},{"key":"2889_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.59462\/JPRD.1.1.101","volume":"1","author":"K Thomas Prasanna","year":"2023","unstructured":"Thomas Prasanna K, Pramod J, Vohra Nitin R, Veligandla Krishna C, Anup PU (2023) A newer approach in the man-agement of cough: A review on levodropropizine. J Respir Dis 1:1\u201314","journal-title":"J Respir Dis"},{"key":"2889_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4081\/mrm.2015.293","volume":"10","author":"A Zanasi","year":"2015","unstructured":"Zanasi A, Lanata L, Fontana G, Saibene F, Dicpinigaitis P, De Blasio F (2015) Levodropropizine for treating cough in adult and children: a meta-analysis of published studies. Multidiscip Respir Med 10:1\u20136","journal-title":"Multidiscip Respir Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02889-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02889-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02889-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T08:24:12Z","timestamp":1716366252000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02889-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2889"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02889-5","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"21 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Clinical studies were conducted in accordance with the Rules of Good Clinical Practice and the revised Declaration of Helsinki for biomedical research involving human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided written informed consent before participating in the bioequivalence and pharmacokinetic studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All data were anonymized, and participants were informed that the results of this study may be subject to publication and presentation in meetings.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The clinical trial protocol was thoroughly reviewed and officially approved by the Ministry of Food and Drug Safety (Cheongju-si, Republic of Korea). The approval number of the trial was 100744, and the approval date was November 1, 2022. The clinical trial was conducted at the Bumin Clinical Trial Center (Seoul, Republic of Korea), and the total duration was from November 30, 2022, to December 9, 2022.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}